Furthermore, we observed that METTL16, a key regulator of m6A modification, was upregulated in BC cells and tissues, which aligns with the findings of Ye et al. [11], who proved METTL16 was upregulated in tumor tissues from BC patients and facilitated BC progression by restraining ferroptosis via regulating GPX4. The gene discussed is GPX4; the disease is breast cancer.